ABBV - BofA starts Sutro at buy cites ovarian cancer drug candidate
2024-05-08 11:28:27 ET
More on Sutro Biopharma
- Sutro Biopharma prices $75M underwritten offering
- Ipsen secures exclusive global rights of Sutro Biopharma's STRO-003 ADC
- Seeking Alpha’s Quant Rating on Sutro Biopharma
- Historical earnings data for Sutro Biopharma
- Financial information for Sutro Biopharma